HK Stock MarketDetailed Quotes

CR MEDICAL (01515)

Watchlist
  • 2.870
  • -0.010-0.35%
Market Closed Apr 17 16:07 CST
3.72BMarket Cap6.78P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CR MEDICAL (01515) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-6.89%9.18B
-9.07%4.52B
-2.50%9.85B
-2.69%4.98B
27.92%10.11B
59.52%5.11B
77.66%7.9B
80.91%3.21B
61.69%4.45B
95.29%1.77B
Operating income
-6.89%9.18B
-9.07%4.52B
-2.50%9.85B
-2.69%4.98B
27.92%10.11B
59.52%5.11B
77.66%7.9B
80.91%3.21B
61.69%4.45B
95.29%1.77B
Cost of sales
3.85%-7.73B
3.24%-3.81B
1.91%-8.04B
2.11%-3.94B
-24.35%-8.2B
-54.77%-4.02B
-87.69%-6.6B
-88.78%-2.6B
-66.21%-3.51B
-108.06%-1.38B
Operating expenses
3.85%-7.73B
3.24%-3.81B
1.91%-8.04B
2.11%-3.94B
-24.35%-8.2B
-54.77%-4.02B
-87.69%-6.6B
-88.78%-2.6B
-66.21%-3.51B
-108.06%-1.38B
Gross profit
-20.39%1.44B
-31.25%712.53M
-5.04%1.81B
-4.86%1.04B
45.95%1.91B
79.91%1.09B
39.88%1.31B
53.45%605.46M
46.67%933.56M
60.84%394.57M
Selling expenses
----
----
77.16%-623K
53.81%-2.44M
86.03%-2.73M
39.88%-5.28M
-16.39%-19.53M
-7.78%-8.78M
-15.06%-16.78M
-30.03%-8.15M
Administrative expenses
5.03%-995.87M
0.28%-470.26M
-8.02%-1.05B
-5.26%-471.58M
-20.05%-970.77M
-43.40%-448.03M
-71.53%-808.66M
-65.58%-312.43M
-45.79%-471.45M
-76.67%-188.69M
Impairment and provision
44.32%-22.31M
-877.34%-11.39M
91.67%-40.07M
134.21%1.47M
-252.13%-481.15M
-32.24%-4.28M
61.54%-136.64M
-506.78%-3.24M
-1,410.26%-355.29M
111.94%796K
-Impairment of intangible assets
----
----
----
----
----
----
----
----
-210.76%-11.15M
----
-Impairment of property, machinery and equipment
99.91%-30K
----
84.61%-32.15M
----
-40,865.88%-208.93M
----
---510K
----
----
----
-Goodwill impairment
----
----
----
----
-30.18%-141.02M
----
---108.32M
----
----
----
-Other impairment is provision
-181.33%-22.28M
-877.34%-11.39M
93.96%-7.92M
134.21%1.47M
-371.88%-131.21M
-32.24%-4.28M
91.92%-27.81M
-506.78%-3.24M
-1,626.13%-344.14M
111.94%796K
Operating interest expense
----
----
----
----
----
----
----
-161.64%-15.38M
-2.55%-17.83M
---5.88M
Special items of operating profit
212.54%296.3M
335.48%257.12M
14.51%94.81M
352.19%59.04M
27.33%82.79M
-23.74%13.06M
-43.32%65.02M
-49.31%17.12M
-8.66%114.72M
-14.59%33.77M
Operating profit
-11.83%718.89M
-21.65%488M
52.69%815.34M
-3.40%622.84M
31.51%533.98M
128.03%644.75M
117.22%406.02M
24.88%282.75M
-51.22%186.92M
37.12%226.43M
Financing cost
34.16%-49.56M
31.42%-27.32M
42.90%-75.28M
34.85%-39.84M
-85.30%-131.84M
---61.15M
---71.15M
----
----
----
Share of profits of associates
-20.55%78.34M
7.04%47.45M
8.62%98.6M
6.74%44.33M
-1.63%90.78M
17.23%41.53M
12.49%92.29M
-17.77%35.43M
142.02%82.04M
861,780.00%43.08M
Share of profit from joint venture company
----
----
----
----
----
----
-377.62%-4.22M
-769.37%-4.22M
41.70%1.52M
54.03%630K
Earning before tax
-10.85%747.67M
-19.00%508.12M
70.14%838.67M
0.35%627.33M
16.55%492.92M
99.11%625.13M
56.37%422.94M
16.22%313.96M
-35.32%270.48M
72.96%270.14M
Tax
-14.76%-191.57M
-15.74%-133.88M
-1.15%-166.92M
16.34%-115.67M
-74.34%-165.03M
-218.82%-138.26M
-160.92%-94.66M
33.10%-43.37M
258.78%155.39M
-41.00%-64.82M
After-tax profit from continuing operations
-17.22%556.1M
-26.86%374.25M
104.87%671.75M
5.09%511.66M
-0.12%327.89M
79.92%486.87M
-22.91%328.28M
31.79%270.6M
32.95%425.86M
86.29%205.33M
Earning after tax
-17.22%556.1M
-26.86%374.25M
104.87%671.75M
5.09%511.66M
-0.12%327.89M
79.92%486.87M
-22.91%328.28M
31.79%270.6M
32.95%425.86M
86.29%205.33M
Minority profit
-43.18%60.15M
-55.31%34.73M
50.79%105.87M
-12.88%77.71M
12.47%70.21M
244.01%89.19M
685.33%62.43M
331.40%25.93M
-21.99%7.95M
143.62%6.01M
Profit attributable to shareholders
-12.36%495.94M
-21.76%339.52M
119.60%565.88M
9.12%433.95M
-3.07%257.68M
62.54%397.68M
-36.39%265.86M
22.75%244.67M
34.75%417.92M
84.97%199.32M
Basic earnings per share
-13.33%0.39
-20.59%0.27
125.00%0.45
9.68%0.34
-4.76%0.2
63.16%0.31
-36.36%0.21
18.75%0.19
32.00%0.33
77.78%0.16
Diluted earnings per share
-13.33%0.39
-20.59%0.27
125.00%0.45
9.68%0.34
-4.76%0.2
63.16%0.31
-36.36%0.21
18.75%0.19
32.00%0.33
77.78%0.16
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
KPMG
--
KPMG
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -6.89%9.18B-9.07%4.52B-2.50%9.85B-2.69%4.98B27.92%10.11B59.52%5.11B77.66%7.9B80.91%3.21B61.69%4.45B95.29%1.77B
Operating income -6.89%9.18B-9.07%4.52B-2.50%9.85B-2.69%4.98B27.92%10.11B59.52%5.11B77.66%7.9B80.91%3.21B61.69%4.45B95.29%1.77B
Cost of sales 3.85%-7.73B3.24%-3.81B1.91%-8.04B2.11%-3.94B-24.35%-8.2B-54.77%-4.02B-87.69%-6.6B-88.78%-2.6B-66.21%-3.51B-108.06%-1.38B
Operating expenses 3.85%-7.73B3.24%-3.81B1.91%-8.04B2.11%-3.94B-24.35%-8.2B-54.77%-4.02B-87.69%-6.6B-88.78%-2.6B-66.21%-3.51B-108.06%-1.38B
Gross profit -20.39%1.44B-31.25%712.53M-5.04%1.81B-4.86%1.04B45.95%1.91B79.91%1.09B39.88%1.31B53.45%605.46M46.67%933.56M60.84%394.57M
Selling expenses --------77.16%-623K53.81%-2.44M86.03%-2.73M39.88%-5.28M-16.39%-19.53M-7.78%-8.78M-15.06%-16.78M-30.03%-8.15M
Administrative expenses 5.03%-995.87M0.28%-470.26M-8.02%-1.05B-5.26%-471.58M-20.05%-970.77M-43.40%-448.03M-71.53%-808.66M-65.58%-312.43M-45.79%-471.45M-76.67%-188.69M
Impairment and provision 44.32%-22.31M-877.34%-11.39M91.67%-40.07M134.21%1.47M-252.13%-481.15M-32.24%-4.28M61.54%-136.64M-506.78%-3.24M-1,410.26%-355.29M111.94%796K
-Impairment of intangible assets ---------------------------------210.76%-11.15M----
-Impairment of property, machinery and equipment 99.91%-30K----84.61%-32.15M-----40,865.88%-208.93M-------510K------------
-Goodwill impairment -----------------30.18%-141.02M-------108.32M------------
-Other impairment is provision -181.33%-22.28M-877.34%-11.39M93.96%-7.92M134.21%1.47M-371.88%-131.21M-32.24%-4.28M91.92%-27.81M-506.78%-3.24M-1,626.13%-344.14M111.94%796K
Operating interest expense -----------------------------161.64%-15.38M-2.55%-17.83M---5.88M
Special items of operating profit 212.54%296.3M335.48%257.12M14.51%94.81M352.19%59.04M27.33%82.79M-23.74%13.06M-43.32%65.02M-49.31%17.12M-8.66%114.72M-14.59%33.77M
Operating profit -11.83%718.89M-21.65%488M52.69%815.34M-3.40%622.84M31.51%533.98M128.03%644.75M117.22%406.02M24.88%282.75M-51.22%186.92M37.12%226.43M
Financing cost 34.16%-49.56M31.42%-27.32M42.90%-75.28M34.85%-39.84M-85.30%-131.84M---61.15M---71.15M------------
Share of profits of associates -20.55%78.34M7.04%47.45M8.62%98.6M6.74%44.33M-1.63%90.78M17.23%41.53M12.49%92.29M-17.77%35.43M142.02%82.04M861,780.00%43.08M
Share of profit from joint venture company -------------------------377.62%-4.22M-769.37%-4.22M41.70%1.52M54.03%630K
Earning before tax -10.85%747.67M-19.00%508.12M70.14%838.67M0.35%627.33M16.55%492.92M99.11%625.13M56.37%422.94M16.22%313.96M-35.32%270.48M72.96%270.14M
Tax -14.76%-191.57M-15.74%-133.88M-1.15%-166.92M16.34%-115.67M-74.34%-165.03M-218.82%-138.26M-160.92%-94.66M33.10%-43.37M258.78%155.39M-41.00%-64.82M
After-tax profit from continuing operations -17.22%556.1M-26.86%374.25M104.87%671.75M5.09%511.66M-0.12%327.89M79.92%486.87M-22.91%328.28M31.79%270.6M32.95%425.86M86.29%205.33M
Earning after tax -17.22%556.1M-26.86%374.25M104.87%671.75M5.09%511.66M-0.12%327.89M79.92%486.87M-22.91%328.28M31.79%270.6M32.95%425.86M86.29%205.33M
Minority profit -43.18%60.15M-55.31%34.73M50.79%105.87M-12.88%77.71M12.47%70.21M244.01%89.19M685.33%62.43M331.40%25.93M-21.99%7.95M143.62%6.01M
Profit attributable to shareholders -12.36%495.94M-21.76%339.52M119.60%565.88M9.12%433.95M-3.07%257.68M62.54%397.68M-36.39%265.86M22.75%244.67M34.75%417.92M84.97%199.32M
Basic earnings per share -13.33%0.39-20.59%0.27125.00%0.459.68%0.34-4.76%0.263.16%0.31-36.36%0.2118.75%0.1932.00%0.3377.78%0.16
Diluted earnings per share -13.33%0.39-20.59%0.27125.00%0.459.68%0.34-4.76%0.263.16%0.31-36.36%0.2118.75%0.1932.00%0.3377.78%0.16
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----KPMG--KPMG--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -